Wright Medical Group NV (NASDAQ:WMGI) insider Peter Cooke sold 20,662 shares of Wright Medical Group stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $29.28, for a total value of $604,983.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Peter Cooke also recently made the following trade(s):
- On Friday, November 2nd, Peter Cooke sold 13,478 shares of Wright Medical Group stock. The stock was sold at an average price of $28.03, for a total value of $377,788.34.
Shares of NASDAQ WMGI traded up $0.44 during trading hours on Friday, hitting $30.19. The company’s stock had a trading volume of 2,891,983 shares, compared to its average volume of 1,230,232. The company has a debt-to-equity ratio of 1.87, a current ratio of 2.06 and a quick ratio of 1.57. Wright Medical Group NV has a 12 month low of $19.01 and a 12 month high of $30.75.
Wright Medical Group (NASDAQ:WMGI) last posted its earnings results on Wednesday, November 7th. The medical device company reported ($0.09) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.15) by $0.06. The company had revenue of $194.11 million for the quarter, compared to analysts’ expectations of $186.09 million. Wright Medical Group had a negative return on equity of 0.70% and a negative net margin of 13.07%. Wright Medical Group’s quarterly revenue was up 13.8% on a year-over-year basis. During the same period last year, the firm earned ($0.16) earnings per share. As a group, research analysts predict that Wright Medical Group NV will post -0.05 EPS for the current fiscal year.
Several research analysts have recently commented on the company. BMO Capital Markets upgraded Wright Medical Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $28.00 to $31.00 in a report on Wednesday, August 29th. Cantor Fitzgerald lifted their price objective on Wright Medical Group from $30.00 to $35.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Piper Jaffray Companies lifted their price objective on Wright Medical Group to $32.00 and gave the stock an “overweight” rating in a report on Thursday, August 9th. Oppenheimer set a $28.00 target price on Wright Medical Group and gave the stock a “hold” rating in a research note on Thursday, August 9th. Finally, Jefferies Financial Group raised their target price on Wright Medical Group from $28.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, August 9th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $32.75.
Several hedge funds and other institutional investors have recently bought and sold shares of WMGI. Amalgamated Bank boosted its position in Wright Medical Group by 14.9% during the 2nd quarter. Amalgamated Bank now owns 16,232 shares of the medical device company’s stock valued at $421,000 after acquiring an additional 2,102 shares in the last quarter. Rhumbline Advisers boosted its position in Wright Medical Group by 4.5% during the 2nd quarter. Rhumbline Advisers now owns 99,783 shares of the medical device company’s stock valued at $2,590,000 after acquiring an additional 4,294 shares in the last quarter. Strs Ohio boosted its position in Wright Medical Group by 850.0% during the 2nd quarter. Strs Ohio now owns 5,700 shares of the medical device company’s stock valued at $147,000 after acquiring an additional 5,100 shares in the last quarter. Principal Financial Group Inc. boosted its position in Wright Medical Group by 7.0% during the 1st quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock valued at $1,841,000 after acquiring an additional 6,084 shares in the last quarter. Finally, Parametrica Management Ltd bought a new stake in Wright Medical Group during the 3rd quarter valued at approximately $204,000.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Recommended Story: Growth Stocks
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.